Elevance Health reaffirms FY2024 net income >$34.05, adjusted >$37.20 per share

Elevance Health, Inc.

Net income guidance for FY2024 greater than $34.05 per diluted share including approximately $3.15 per share of net unfavorable items.
Adjusted net income guidance greater than $37.20 per diluted share, excluding the unfavorable items.
Guidance does not include any adjustment items beyond those reported in Q1 2024 earnings release.
Company officers reaffirming guidance during investor meetings over the next several weeks.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.